Archive | ARTES Biotechnology GmbH

Page 1 of 5
Bringing microbial CDMO services to BIO International 2025 in Boston
Bringing microbial CDMO services to BIO International 2025 in Boston Learn More >
ARTES showing ‘white biotechnology’ advantages at Jülich Biotech Day
ARTES showing ‘white biotechnology’ advantages at Jülich Biotech Day Learn More >
ARTES presenting at BIO-Europe Stockholm
ARTES presenting at BIO-Europe Stockholm Learn More >
ARTES and Basic Pharma near rHSA protein production
ARTES and Basic Pharma near rHSA protein production Learn More >
54490ARTES recombinant antigens, proteins, and enzymes
ARTES recombinant antigens, proteins, and enzymes Learn More >
ARTES announce expansion of the management board
ARTES announce expansion of the management board Learn More >
ARTES adds direct reagent sales for laboratories
ARTES adds direct reagent sales for laboratories Learn More >
ARTES presenting innovative vaccine technologies at BIO-Europe Munich
ARTES presenting innovative vaccine technologies at BIO-Europe Munich Learn More >
ARTES partners with Basic Pharma to advance recombinant protein production
ARTES partners with Basic Pharma to advance recombinant protein production Learn More >
ARTES to present innovative microbial expression technologies for API development at European Pharma Partnering Summit
ARTES to present innovative microbial expression technologies for API development at European Pharma Partnering Summit Learn More >
ARTES sponsors 6th BioProcessingDays conference
ARTES sponsors 6th BioProcessingDays conference Learn More >
52042ARTES heterologous production of holoproteins in Hansenula polymorpha yeast
ARTES heterologous production of holoproteins in Hansenula polymorpha yeast Learn More >
Page 1 of 5